Branded vial and pen-kit presentation. Confirm the available format, contents and packaging for this product.
Ipamorelin + CJC (no DAC)
A combined growth hormone signalling research presentation. Request the exact ratio.
Listed content per unit- Presentation
- Blend in vial presentation
- Local dispatch markets
- Australia · Canada · USA
- Availability
- Confirm by strength & location
- Documentation
- Request product & batch records
For qualified research enquiries. Listed content is not a dose or administration instruction.
The research context
This pairing brings together a growth hormone secretagogue and a GHRH-related peptide. Exact sequence, component amounts and the combined total should be defined for each specification.
The expression “CJC without DAC” is a trade description and should be matched to molecular identity. Findings from long-acting, DAC-linked CJC-1295 cannot be assumed to describe a no-DAC material.
For component amounts and unresolved totals across the collection, see the research peptide blends comparison guide.
Keep the no DAC designation and both component names together. Our CJC-1295 DAC vs no DAC naming guide explains which identity and formulation details to request.
For a direct comparison of the peptide identities, research pathways and catalogue presentations, read our Ipamorelin vs Sermorelin guide.
What to include in your enquiry
Tell us your required compound, strength, presentation and destination country. If you have a particular analytical requirement, include the method or document you need so the team can match your request to the relevant specification.
Selected scientific references
These sources describe published research or a specific regulated medicine. They are not certificates for an Aurelis batch.
Explore related entries.
All compoundsKLOW
A blend presentation featuring GHK, BPC and KPV. Request the complete formulation.
GLOW
A three-component blend listed as GHK 50 mg, BPC 10 mg and TB 10 mg.
Wolverine
A two-component blend listed as BPC 10 mg and TB 10 mg.
Connect with Aurelis
Your next enquiry
starts with the details.
Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.